Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer

Table 6

The differences between metastatic and nonmetastatic patients with inoperable gastric adenocarcinoma in terms of PG-SGA, GPS, and PCPS.

	Metastatic	Nonmetastatic	P value
PG-SGA (%)
A	12	19
B	48	44
C	40	37	0.820
GPS^# (%)
0	16	36
1	40	41
2	44	23	0.153
PCPS (%)
0	9	27
1	15	37
2	76	36	0.009

Patient generated subjective global assessment.
value was calculated based on exact Chi-square test.
^#Glasgow Prognostic Score.
Prealbumin/CRP based prognostic score.